Clinical Trial: A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087314) titled 'A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence' on July 09.

Brief Summary: This is an open - label study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of SG301 Subcutaneous injection in children with frequently relapsing or steroid - dependent nephrotic syndrome.

Study Start Date: July 19

Study Type: INTERVENTIONAL

Condition: Nephrotic Syndrome in Children

Intervention: DRUG: SG301 Subcutaneous injection

Subcutaneous injection every weeks (QW*6),subsequently, administer it once every...